Bachem Holding AG (BCHMF)

Market Cap	5.54B
Revenue (ttm)	642.97M
Net Income (ttm)	126.38M
Shares Out	n/a
EPS (ttm)	1.69
PE Ratio	43.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	382
Open	74.45
Previous Close	n/a
Day's Range	74.45 - 74.45
52-Week Range	87.51 - 97.06
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,006
• Stock Exchange: OTCMKTS
• Ticker Symbol: BCHMF

Financial Performance

In 2023, Bachem Holding AG's revenue was 577.32 million, an increase of 8.57% compared to the previous year's 531.74 million. Earnings were 111.86 million, an increase of 11.10%.

Financial numbers in CHF